First-degree living-related donor liver transplantation in autoimmune liver diseases
from American Journal of Transplantation (login required)
From May 30:
Liver transplantation is the treatment of choice for end-stage autoimmune liver diseases. However, the underlying disease may recur in the graft in some 20 percent of cases. The aim of this study is to determine whether LT using living donor grafts from first-degree relatives results in higher rates of recurrence than grafts from more distant/unrelated donors. Two hundred sixty-three patients, who underwent a first LT in the Toronto liver transplant program between January 2000 and March 2015 for autoimmune liver diseases, and had at least 6 months of post-LT follow-up, were included in this study.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063